Product image of Movicol Paediatric Plain (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350) supplied by GNH India

Movicol Paediatric Plain

Active Ingredient:
Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350
Origin:
EU

Movicol Paediatric Plain (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350, the active ingredient in Movicol Paediatric Plain, is an osmotic laxative presented as an oral solution for oral use. It is indicated for the treatment of constipation in children, including faecal impaction, and may be used to prepare the bowel for diagnostic procedures.

GNH India supplies Movicol Paediatric Plain as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance, and reliable delivery across global markets today.

Manufacturer / TM Owner

Norgine Pharmaceuticals Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Movicol Paediatric Plain, an osmotic laxative, is used to manage conditions affecting bowel motility and stool consistency.

  • Constipation in children: softens stools and facilitates easier passage.
  • Faecal impaction: helps relieve hardened stool blockage in the colon.
  • Bowel preparation for diagnostic procedures: clears the intestinal tract to improve visualization.
  • Chronic functional constipation: promotes regular bowel movements and reduces stool hardness.

How It Works

  • Macrogol 3350 remains largely unabsorbed in the gastrointestinal tract, generating an osmotic gradient that draws water into the lumen. The resulting increase in fluid volume softens stool, expands the intestinal lumen, and stimulates peristalsis, thereby facilitating fecal passage. The accompanying electrolytes (sodium hydrogen carbonate, potassium chloride, sodium chloride) help maintain electrolyte balance during this process.

Side Effects

The most frequently reported reactions with Movicol Paediatric Plain are related to gastrointestinal tolerance, while rare events may indicate more serious concerns.

Common Side Effects

  • Abdominal bloating
  • Nausea
  • Flatulence
  • Diarrhoea

Serious or Rare Side Effects

  • Severe dehydration
  • Electrolyte imbalance (e.g., hyponatraemia, hypokalaemia)
  • Allergic reactions such as rash or angio‑edema
  • Intense abdominal pain

Precautions & Warnings

Before initiating therapy with Movicol Paediatric Plain, consider the following precautions to ensure safe and effective use.

  • Assess hydration status: confirm adequate fluid intake before and during treatment.
  • Review electrolyte balance: monitor serum sodium and potassium, especially in patients with renal or cardiac disease.
  • Evaluate bowel obstruction risk: avoid use in known mechanical obstruction or severe ileus.
  • Adjust dose in renal impairment: consider reduced dosing or increased monitoring.
  • Use with caution in children with metabolic disorders: assess risk of electrolyte shifts.
  • Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Movicol Paediatric Plain may interact with other medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

  • Concurrent use of other osmotic laxatives: may cause excessive fluid loss and electrolyte disturbances.
  • High‑dose electrolyte supplements (e.g., potassium chloride): increase risk of hyperkalaemia.

Moderate Interactions (Monitor Closely)

  • Anticholinergic agents (e.g., atropine): may reduce laxative efficacy.
  • Loop or thiazide diuretics: monitor electrolytes for additive effects.
  • Oral rehydration solutions: adjust electrolyte content to avoid imbalance.
  • Certain antibiotics (e.g., quinolones) that require optimal intestinal pH: monitor therapeutic levels.

Frequently Asked Questions

Movicol Paediatric Plain is an oral osmotic laxative indicated for the treatment of constipation in children, including relief of faecal impaction, and for bowel cleansing prior to diagnostic procedures such as colonoscopy or radiographic imaging.

Macrogol 3350 acts as a large, non‑absorbed polymer that retains water in the intestinal lumen through osmotic activity. The increased fluid softens stool, expands the bowel contents, and stimulates peristalsis, making it easier for the patient to pass feces.

The dose of Movicol Paediatric Plain is individualized by the prescribing clinician based on the child’s age, weight, severity of constipation, and response to therapy. No fixed regimen is provided here; the prescriber sets the appropriate amount.

Safety data for macrogol‑based laxatives in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified health professional.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives, macrogol‑based solutions like Movicol Paediatric Plain act by osmotic water retention rather than stimulating intestinal muscle activity, resulting in a gentler, more physiologic stool softening and a lower incidence of cramping.

Store at ambient temperature, preferably below 25 °C. Keep the bottle tightly closed in its original packaging, protect it from moisture, direct sunlight and excessive heat to maintain product stability.

The medication is supplied as an oral liquid. It is usually mixed with a measured amount of water or a suitable beverage and given by mouth according to the dose prescribed by the health‑care professional.

Serious risks include severe dehydration, significant electrolyte disturbances such as hyponatraemia or hypokalaemia, and rare allergic reactions that may present as rash, swelling or anaphylaxis. Prompt medical attention is required if these occur.

The product should be avoided in children with known mechanical bowel obstruction, severe ileus, hypersensitivity to any of its ingredients, or in cases of uncontrolled renal or cardiac disease where electrolyte shifts could be hazardous.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.